Irisin deficiency disturbs bone metabolism
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Balancing the process of bone formation and resorption is important in the maintenance of healthy bone. Therefore, the discovery of novel factors that can regulate bone metabolism remains needed. Irisin is a newly identified hormone‐like peptide. Recent studies have reported the involvement of irisin in many physiological and pathological conditions with bone mineral density changes, including osteopenia and osteoporotic fractures. In this study, we generated the first line of Osx‐Cre:FNDC5/irisin KO mice, in which FNDC5/irisin was specifically deleted in the osteoblast lineage. Gene and protein expressions of irisin were remarkably decreased in bones but no significant differences in other tissues were observed in knockout mice. FNDC5/irisin deficient mice showed a lower bone density and significantly delayed bone development and mineralization from early‐stage to adulthood. Our phenotypical analysis exhibited decreased osteoblast‐related gene expression and increased osteoclast‐related gene expression in bone tissues, and reduced adipose tissue browning due to bone‐born irisin deletion. By harvesting and culturing MSCs from the knockout mice, we found that osteoblastogenesis was inhibited and osteoclastogenesis was increased. By using irisin stimulated wildtype primary cells as a gain‐of‐function model, we further revealed the effects and mechanisms of irisin on promoting osteogenesis and inhibiting osteoclastogenesis in vitro. In addition, positive effects of exercise, including bone strength enhancement and body weight loss were remarkably weakened due to irisin deficiency. Interestingly, these changes can be rescued by supplemental administration of recombinant irisin during exercise. Our study indicates that irisin plays an important role in bone metabolism and the crosstalk between bone and adipose tissue. Irisin represents a potential molecule for the prevention and treatment of bone metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · cited 4×
“…function of exogenous r‐irisin and muscle secreted irisin in adipose tissue browning, inducing weight loss via the PGC‐1α/Irisin/UCP‐1 pathway during exercise (Boström et al., 2012; Dinas et al., 2017; Niranjan, Belwalkar, Tambe, Venkataraman, & Mookhtiar, 2019; J. Zhang, Valverde, et al., 2017).”
BackgroundInfluentialPrevention and treatment of postmenopausal osteoporosis
Tella, S. H., & Gallagher, J. C. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.09.008 · Cited by 786
Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors
Kim, H., Wrann, C. D., Jedrychowski, M., Vidoni, S., Kitase, Y., Nagano, K., Zhou, C., Chou, J., Parkman, V.-J. A., Novick, S. J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.025 · Cited by 638
Polyzos, S. A., Anastasilakis, A. D., Efstathiadou, Z. A., Makras, P., Perakakis, N., Kountouras, J., & Mantzoros, C. S. (2018) · Endocrine · doi:10.1007/s12020-017-1476-1 · Cited by 262
Allen, M. R., & Burr, D. B. (2014) · Basic and Applied Bone Biology · doi:10.1016/b978-0-12-416015-6.00004-6 · Cited by 133 · cited 1×
“The biology of bone during mineral metabolism, especially the tightly coupled balance between bone formation by osteoblasts and bone resorption by osteoclasts, remains a challenge to clinical and basic science researchers (Seeman, 2009; Sims & Martin, 2014).”
BackgroundDinas, P. C., Lahart, I. M., Timmons, J. A., Svensson, P.-A., Koutedakis, Y., Flouris, A. D., & Metsios, G. S. (2017) · F1000Research · doi:10.12688/f1000research.11107.2 · Cited by 51 · cited 1×
“…function of exogenous r‐irisin and muscle secreted irisin in adipose tissue browning, inducing weight loss via the PGC‐1α/Irisin/UCP‐1 pathway during exercise (Boström et al., 2012; Dinas et al., 2017; Niranjan, Belwalkar, Tambe, Venkataraman, & Mookhtiar, 2019; J. Zhang, Valverde, et al., 2017).”
Background
Cited by
Progress and Challenges in the Biology of FNDC5 and Irisin
Maak, S., Norheim, F., Drevon, C. A., & Erickson, H. P. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab003 · Cited by 247
“They did not reference the results of other groups who also found irisin enhanced bone formation (120, 124, 125).”
BackgroundMethodResultInfluentialFNDC5/Irisin: Physiology and Pathophysiology
Waseem, R., Shamsi, A., Mohammad, T., Hassan, M. I., Kazim, S. N., Chaudhary, A. A., Rudayni, H. A., Al-Zharani, M., Ahmad, F., & Islam, A. (2022) · Molecules · doi:10.3390/molecules27031118 · Cited by 180
“More recently, irisin deficiency has been shown to cause disturbance in bone metabolism [68].”
BackgroundIrisin, an exercise-induced bioactive peptide beneficial for health promotion during aging process
Zhang, H., Wu, X., Liang, J., Kirberger, M., & Chen, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101680 · Cited by 88
Sun, B., Wu, H., Lu, J., Zhang, R., Shen, X., Gu, Y., Shi, C., Zhang, Y., & Yuan, W. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2022.10.012 · Cited by 28
Metadata
- Authors
- Zhu, X., Li, X., Wang, X., Chen, T., Tao, F., Liu, C., Tu, Q., Shen, G., & Chen, J. J.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2020-06-22
- Volume
- 236
- Issue
- 1
- Pages
- 664-676
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W3037145231
- Cited by
- 71
- References
- 6
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Irisin deficiency disturbs bone metabolism. https://app.cochat.ai/papers/10.1002/jcp.29894
- The paper
- Zhu, X., Li, X., Wang, X., Chen, T., Tao, F., Liu, C., Tu, Q., Shen, G., & Chen, J. J. (2021). Irisin deficiency disturbs bone metabolism. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.29894
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.